Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections

Book Chapter

Authors:

Secondary:
Best Pharmaceuticals for Children Act (BPCA) Clinical Reports

Location:
Bethesda, MD

PMID:
36630542

URL:
https://www.ncbi.nlm.nih.gov/pubmed/36630542

Abstract:
<p>An open-label, multiple-dose study to determine the safety, tolerability, and pharmacokinetics of meropenem in preterm and term infants less than 91 days of age with suspected or confirmed intra-abdominal infections. Biospecimens are available.</p>